Loading...
Disclaimer: Informational only — not medical advice. AI hypotheses are not clinically validated. Medic Oath is for informational and educational purposes only — not medical advice. AI-generated hypotheses have not been clinically validated. Always consult a qualified healthcare professional. Privacy · Terms
Eight pharmaceutical companies earned £1.12 trillion last year. Thousands of diseases have zero approved treatments. Every number on this page is from their own public financial filings. Every disease listed has real patients waiting for cures that will never be profitable enough to pursue.
Medic Oath removes profit as a gatekeeper. Our AI generates cure hypotheses for £1.58 each. Open. Auditable. Unstoppable.
Revenue data from SEC filings and annual reports. Neglect scores from Medic Oath analysis of global R&D spending, clinical trial counts, and disease burden.
FY2023 figures
“Pfizer makes your child's entire lifetime of Progeria research funding every 9 minutes.”
FY2023 figures
“J&J spent £5.5B on stock buybacks in 2023. The entire global Sleeping Sickness research budget is £55M.”
FY2023 figures
“Roche earned more in Q1 2023 than the entire history of ME/CFS research funding combined.”
FY2023 figures
“Novartis CEO compensation in 2023: £12.8M. Total PSP research funding globally: £9.5M.”
What if just 0.1% of pharma revenue went to neglected disease discovery?
7.1 million AI-generated cure hypotheses
71 million hypotheses + 1,000 in-silico clinical trials
Enough to investigate every neglected disease on earth
More than the entire current global neglected disease R&D budget
Medic Oath is AI medical research. We took ours. Join us.
All revenue figures sourced from SEC 10-K filings and company annual reports (FY2023). Neglect scores computed by Medic Oath from WHO disease burden data, NIH RePORTER funding data, ClinicalTrials.gov trial counts, and PubMed publication volumes. This page contains no allegations of wrongdoing -- only public data and the questions it raises.